The Clinical Development Program of Lixisenatide: A Once-Daily Glucagon-Like Peptide-1 Receptor Agonist

por Bain, Stephen C.
Publicado 2014

The Cellnovo Insulin Delivery System

por Bain, Stephen C
Publicado 2017

Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond

por Viljoen, Adie, Bain, Stephen C.
Publicado 2023

A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment

por Eligar, Vinay S, Bain, Stephen C
Publicado 2013

The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials

por Min, Thinzar, Bain, Stephen C.
Publicado 2020

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus

por Seewoodhary, Jason, Griffin, Leanne, Bain, Stephen C
Publicado 2010

Recent advances in understanding the role of glucagon-like peptide 1

por Reed, Josh, Bain, Stephen C., Kanamarlapudi, Venkateswarlu
Publicado 2020

Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data

por Chudleigh, Richard A, Platts, Julia, Bain, Stephen C
Publicado 2020

One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus

por Evans, Marc, Morgan, Angharad R., Bain, Stephen C.
Publicado 2021

Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation

por Thompson, Aiysha, Stephens, Jeffrey W., Bain, Stephen C., Kanamarlapudi, Venkateswarlu
Publicado 2016

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity

por Williams, David M, Staff, Matthew, Bain, Stephen C, Min, Thinzar
Publicado 2022

Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review

por Bain, Stephen C., Klufas, Michael A., Ho, Allen, Matthews, David R.
Publicado 2018

Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials

por Fulcher, Greg, Mehta, Roopa, Fita, Edmond G., Ekelund, Magnus, Bain, Stephen C.
Publicado 2018

Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK

por Viljoen, Adie, Hoxer, Christina S., Johansen, Pierre, Malkin, Samuel, Hunt, Barnaby, Bain, Stephen C.
Publicado 2018

Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review

por Fernando, Kevin, Bain, Stephen C., Holmes, Patrick, Jones, Philip Newland, Patel, Dipesh C.
Publicado 2021

IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy

por Freemantle, Nick, Mamdani, Muhammad, Vilsbøll, Tina, Kongsø, Jens Harald, Kvist, Kajsa, Bain, Stephen C.
Publicado 2015

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials

por Husain, Mansoor, Bain, Stephen C., Holst, Anders Gaarsdal, Mark, Thomas, Rasmussen, Søren, Lingvay, Ildiko
Publicado 2020

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

por Viljoen, Adie, Chubb, Barrie, Malkin, Samuel J. P., Berry, Sasha, Hunt, Barnaby, Bain, Stephen C.
Publicado 2022

Supplementary Nitric Oxide Donors and Exercise as Potential Means to Improve Vascular Health in People with Type 1 Diabetes: Yes to NO?

por McCarthy, Olivia, Moser, Othmar, Eckstein, Max L., Bain, Stephen C., Pitt, Jason, Bracken, Richard
Publicado 2019

The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell

por McCarthy, Olivia, Schmidt, Signe, Christensen, Merete Bechmann, Bain, Stephen C., Nørgaard, Kirsten, Bracken, Richard
Publicado 2022